Clinuvel

Frogster

Well-known member
As I’ve never bought CLVLY I’m wondering if anyone has any concerns holding it as opposed to CUV? Other than voting issues is there any reason why it might not be a good idea to hold it in place of CUV? Liquidity? Future hassle with NASDAQ listing etc?
My thought is that maximising voting rights through holding CUV (if you have that option) is a pretty big priority. To have a healthly, functional, truly representative democracy - in whatever setting you consider - you need to have maximum representation and minimal disenfranchisement. The views of ADR holders, whatever they may be, are unheard at AGM time.
 
Last edited:

George111

Well-known member
The problem is not the shorters. They are simply opportunists. Clinuvel provides them with that in spades. The problem has been and continues to be arrogance in management.Keeping shareholders from voting, stacking the board with yes men, poor hiring decisions, hoarding cash instead of hiring professionals in the field, inability to admit mistakes, dishonesty when confronted with inaccuracies, refusing to release relevant information to stakeholders and speaking in ambiguous code when they do. The arrogance is almost baffling and with it the inability to consider alternatives. They know best, end of story. Just trust us or move along insects. Pay us more, we are amazing and you don’t want to lose us. Unfortunately trust is earned and Clinuvel has given very little to deserve this trust iof the broader market let alone its own stakeholders. I would give up half my shares for a new CEO who valued transparency, integrity and courage.
 

Billy Boots

Well-known member
@George111 Wouldn't we all my friend you speak the real facts, just watch out or some on this board will call you a whinger. Believe me I agree wholeheartedly with you 100%. The TRUTH as she is spoken ,remember I'm an Aussie. ;) Our CEO is a sleaze.......doesn't it now show true colours?
 
Last edited:

FarmaZutical

Well-known member
I believe Wolgen said in a recent interview, that he doesn’t look at Yahoo Finance too often, because the share price didn’t reflect the true value of the company. He’s probably right, but it’s easy to say when you have your heftily salary and free stock. He can continue like this for years - indefinitely actually - and still be super wealthy. My personal opinion is that remuneration and intensives in this company are constructed in a very counterproductive way. I think the rem report was voted through because many were blinded by promises and probably also fear of loosing momentum. Now, we have more delays and seemingly no momentum. In my opinion it was a lost chance, because I simply can’t see what the real incentives are to protect shareholder value. Yes, the CEO is a shareholder too, but the truckloads of free shares are largely enough to make him wealthy even though the share price declines from here. The real incentive would lie in all or nothing options. Reach this share price and you will get x number of free shares in return. If not, you get diddly-squat. Right now, it’s more like “enjoy 4 cheese burgers in your own time and we will give you 30.000 free Big Macs.” Yes, he would be significantly more wealthy if the share price reached $100. But even if it doesn’t, he will still be super rich. What we need is a lower salary, real incentives and accountability. Otherwise, the shorting and the falling share price will be nothing but a nuisance and perhaps a personally humiliation, but that doesn’t seem to bother too much.
 

DenzelWash

Well-known member
So much negativity on the Board recently and I am just sitting here and constantly collecting more and more shares at this ridiculous price😁 yesterday I thought I would need new shoes since it is getting colder but f*** it since this would be equal to 3 Clinuvel shares so I bought Clinuvel instead…last week I needed to go to the grocery store and my car required gas but f*** it since this would be equal to 2 Clinuvel shares so I bought Clinuvel instead and took the bike. Love you guys it will all pay off in the end❤
 

Jalu06

Well-known member
I bought yesterday, but i dont care.
Next month I can buy even lower! (lol)

Can we expect a newsletter next week or the week after?
I just hope for some updates on ACTH and how they plan to distribute it.
And maybe they could describe how they plan to conduct Phase 3 trials for CV indications where a sample size >1000 is needed when a stroke trial stuck with 6 patients :D
And they could write something about the Vitiligo competition (Incyte NDA filling). Maybe some more as just a Henry Ford quote.

I have some questions but I would be happy if they answer only one of them.
 

George111

Well-known member
So much negativity on the Board recently and I am just sitting here and constantly collecting more and more shares at this ridiculous price😁 yesterday I thought I would need new shoes since it is getting colder but f*** it since this would be equal to 3 Clinuvel shares so I bought Clinuvel instead…last week I needed to go to the grocery store and my car required gas but f*** it since this would be equal to 2 Clinuvel shares so I bought Clinuvel instead and took the bike. Love you guys it will all pay off in the end❤
I appreciate the optimism. I was able to keep that up for 20 years. Guess I found my limit.
 

CUV Quote (Yesterday's close)

Time: 10:29AM AEDT
Price: 22.44
Volume: 32488
Top